 |
|
Solexa and collaborating scientists illuminate the small RNA component of the transcriptome
September 07, 2005Research published in Science demonstrates the value of high-throughput sequencing in small RNA analysis
HAYWARD, Calif. - Solexa, Inc. (Nasdaq: SLXA) today announced that its researchers in collaboration with the Delaware Biotechnology Institute and the University of Delaware reported the most comprehensive analysis to date of the small RNA component of the transcriptome. The research, "Elucidation of the Small RNA Component of the Transcriptome," was published in the September 2, 2005 issue of the peer-reviewed journal Science. Solexa's assay can be used to elucidate small RNAs in any plant or animal species, notably humans.
"Finding that small RNAs comprise a potent set of regulatory molecules in diverse organisms is among the most important discoveries in the past 10 years," stated John West, Solexa's chief executive officer. "This research is pioneering in its ability to characterize these important regulatory molecules on a genome-wide scale."
Solexa's technology has the advantage of producing highly accurate, reproducible and quantitative readouts of the full complement of activated genes and small RNAs, including genes expressed at low levels, without requiring advance knowledge of the genes or sequences of interest. Solexa performed this research in its Genomic Services business unit. The Company also intends to develop this small RNA assay for use with its next-generation sequencing platform, which is scheduled to be introduced to the market by the end of this year.
Using Solexa's unique high-throughput sequencing technology, the study identified over 77,000 unique small RNAs in Arabidopsis plants, 10 times more than previously known. This study, funded by the National Science Foundation, generated more than two million short DNA sequences, known as signature sequences or sequence tags, to identify and quantify both known and novel small RNA molecules. Many regions of the Arabidopsis genome previously considered to be inactive or featureless were found to be sites of considerable small RNA activity.
"The signature sequencing approach makes possible the study of global identity, regulation and function of small RNA populations in diverse organisms. This extensive small RNA data will help biologists understand small RNAs and their regulation," said Blake Meyers, an Assistant Professor at the University of Delaware and a senior author on the study. "We have also released an enhanced version of our Arabidopsis MPSS website (http://mpss.udel.edu/at) to further facilitate public access and use of these data."
"These experiments underscore the importance of studying the entire genome for evidence of small RNA activity. The newly discovered small RNAs that match to genes are exciting, but so are those that derive from relatively featureless regions between genes," added Pamela J. Green, a professor at the University of Delaware and the Delaware Biotechnology Institute, another senior author on the study.
About small RNAs
The two major categories of small RNAs are microRNAs (miRNAs) and small interfering RNAs (siRNAs). Small RNAs function to silence genes by inhibiting the synthesis or function of mRNA. Deficiencies in small RNA production can have a profound effect on development, and small RNAs have been associated with other important biological processes such as stress responses. In addition, recent data suggests a possible role for small RNA profiling in cancer diagnostics.
About Solexa
Solexa, Inc. is developing and preparing to commercialize a new genetic analysis instrument system which will be used to perform a range of analyses including whole genome resequencing, gene expression analysis and small RNA analysis. We expect the first generation of Solexa's new technology to generate over a billion bases of DNA sequence per run and to enable whole genome resequencing below $100,000 per sample, making it the first platform to reach this important milestone. Solexa's longer-term goal is to reduce the cost of human re-sequencing to a few thousand dollars for use in a wide range of applications from basic research through clinical diagnostics. The Company expects to introduce its first instrument system by the end of 2005. For further information, please visit www.solexa.com.
This press release contains "forward-looking" statements, including statements related to the current views of Solexa management as to future products, product development including the commercial introduction of the Company's novel genetic analysis technology, the expansion and success of Solexa's commercial application of its genomics technologies and the future financial performance of Solexa. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "predicts," "expects," "envisions," "hopes," "estimates," "intends," "will," "continue," "may," "potential," "should," "confident," "could" and similar expressions are intended to identify forward-looking statements. There can be no assurance that such expectations of any of the forward-looking statements will prove to be correct, and actual results could differ materially from those projected or assumed in the forward-looking statements. There are a number of important factors that could cause the results of Solexa to differ materially from those indicated by these forward-looking statements including, among others, risks detailed from time to time in the Company's SEC reports, including its Annual Report on Form 10-K for the year ended December 31, 2004 and its Form 10-Q for the quarter ended June 30, 2005. Solexa does not undertake any obligation to update forward-looking statements.
Lippert/Heilshorn and Associates
Solexa's technology has the advantage of producing highly accurate, reproducible and quantitative readouts of the full complement of activated genes and small RNAs, including genes expressed at low levels, without requiring advance knowledge of the genes or sequences of interest. Solexa performed this research in its Genomic Services business unit. The Company also intends to develop this small RNA assay for use with its next-generation sequencing platform, which is scheduled to be introduced to the market by the end of this year.
Using Solexa's unique high-throughput sequencing technology, the study identified over 77,000 unique small RNAs in Arabidopsis plants, 10 times more than previously known. This study, funded by the National Science Foundation, generated more than two million short DNA sequences, known as signature sequences or sequence tags, to identify and quantify both known and novel small RNA molecules. Many regions of the Arabidopsis genome previously considered to be inactive or featureless were found to be sites of considerable small RNA activity.
"The signature sequencing approach makes possible the study of global identity, regulation and function of small RNA populations in diverse organisms. This extensive small RNA data will help biologists understand small RNAs and their regulation," said Blake Meyers, an Assistant Professor at the University of Delaware and a senior author on the study. "We have also released an enhanced version of our Arabidopsis MPSS website (http://mpss.udel.edu/at) to further facilitate public access and use of these data."
"These experiments underscore the importance of studying the entire genome for evidence of small RNA activity. The newly discovered small RNAs that match to genes are exciting, but so are those that derive from relatively featureless regions between genes," added Pamela J. Green, a professor at the University of Delaware and the Delaware Biotechnology Institute, another senior author on the study.
About small RNAs
The two major categories of small RNAs are microRNAs (miRNAs) and small interfering RNAs (siRNAs). Small RNAs function to silence genes by inhibiting the synthesis or function of mRNA. Deficiencies in small RNA production can have a profound effect on development, and small RNAs have been associated with other important biological processes such as stress responses. In addition, recent data suggests a possible role for small RNA profiling in cancer diagnostics.
About Solexa
Solexa, Inc. is developing and preparing to commercialize a new genetic analysis instrument system which will be used to perform a range of analyses including whole genome resequencing, gene expression analysis and small RNA analysis. We expect the first generation of Solexa's new technology to generate over a billion bases of DNA sequence per run and to enable whole genome resequencing below $100,000 per sample, making it the first platform to reach this important milestone. Solexa's longer-term goal is to reduce the cost of human re-sequencing to a few thousand dollars for use in a wide range of applications from basic research through clinical diagnostics. The Company expects to introduce its first instrument system by the end of 2005. For further information, please visit www.solexa.com.
This press release contains "forward-looking" statements, including statements related to the current views of Solexa management as to future products, product development including the commercial introduction of the Company's novel genetic analysis technology, the expansion and success of Solexa's commercial application of its genomics technologies and the future financial performance of Solexa. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "predicts," "expects," "envisions," "hopes," "estimates," "intends," "will," "continue," "may," "potential," "should," "confident," "could" and similar expressions are intended to identify forward-looking statements. There can be no assurance that such expectations of any of the forward-looking statements will prove to be correct, and actual results could differ materially from those projected or assumed in the forward-looking statements. There are a number of important factors that could cause the results of Solexa to differ materially from those indicated by these forward-looking statements including, among others, risks detailed from time to time in the Company's SEC reports, including its Annual Report on Form 10-K for the year ended December 31, 2004 and its Form 10-Q for the quarter ended June 30, 2005. Solexa does not undertake any obligation to update forward-looking statements.
Lippert/Heilshorn and Associates
RNA Current Events and RNA News RSSBold traveler's journey toward the center of the Earth
The first ecosystem ever found having only a single biological species has been discovered 2.8 kilometers (1.74 miles) beneath the surface of the earth in the Mponeng gold mine near Johannesburg, South Africa.
Brainy genes, not brawn, key to success on mussel beach
It's hard being a mussel: you have to worry about hungry starfish and even hungrier humans, not to mention an environment that can change your body temperature 50 degrees Fahrenheit in just a few hours.
RNA molecules, delivery system improve vaccine responses, effectiveness
A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin.
Researchers discover that SLC2A9 is a high-capacity urate transporter in humans
An international team of researchers led by Professors Mark Caulfield and Patricia Munroe, from the William Harvey Research Institute at Barts and The London School of Medicine and Dentistry with Chris Cheeseman at the University of Alberta in Canada and Kelle Moley at the University of Washington in USA, have shown that the SLC2A9 gene, which encodes a glucose transporter, is also a high-capacity urate transporter, and thus possibly a new drug target for gout.
Early-stage gene transcription creates access to DNA
A gene contained in laboratory yeast has helped an international team of researchers uncover new findings about the process by which protein molecules bind to control sequences in genes in order to initiate gene expression, according to findings reported in the journal Nature.
Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
Novel platform technologies and key advances in genomics are rapidly driving the development of molecular diagnostics, reports Genetic Engineering and Biotechnology News (GEN).
Nanodiamond drug device could transform cancer treatment
A Northwestern University research team has developed a promising nanomaterial-based biomedical device that could be used to deliver chemotherapy drugs locally to sites where cancerous tumors have been surgically removed.
Urbanization in Africa at dawn of 20th century marked outbreak of HIV
New research indicates that the most pervasive global strain of HIV began spreading among humans between 1884 and 1924, suggesting that growing urbanization in colonial Africa set the stage for the HIV/AIDS pandemic.
HIV drug maraviroc effective for drug-resistant patients
As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death.
Algal biomonitor
A paper published in the current issue of the International Journal of Environment and Pollution, explains how a DNA test can be used to detect harmful algal blooms across the globe.
More RNA Current Events and RNA News Articles
 | The Rna World (Cold Spring Harbor Monograph Series) (Cold Spring Harbor Monograph Series) Recent studies on the activities of RNA in the cell have revolutionized our understanding of the many roles played by this molecule. The first two editions of The RNA World (1993, 1999) shed light on the pre–biotic era dominated by this versatile molecule, and provided an overview of the state of RNA research at the time. The new third edition of The RNA World updates this perspective,... |
 | Small RNAs:: Analysis and Regulatory Functions (Nucleic Acids and Molecular Biology) In recent years Molecular Biology has experienced an unprecedented revolution by the discovery of functional small RNAs. The number of cellular processes in which non-coding RNAs are involved is growing rapidly and include gene regulation on the transcriptional, post-transcriptional and translational level. To complicate matters, these processes seem to be strongly interconnected on the one hand,... |
 | Non-Coding RNAs: Molecular Biology and Molecular Medicine (Molecular Biology Intelligence Unit (Unnumbered).) General inspection of a role performed in the cell by RNAs allows us to distinguish three major groups of transcripts: I. protein-coding mRNAs, II. non-coding housekeeping and III. regulatory RNAs. The housekeeping RNAs include RNA classes that are generally, constitutively expressed and whose presence is required for normal function and viability of the cells. On the other hand, a group of... |
 | Handbook of RNA Biochemistry. 2 Vol.Set This all-in-one compendium of current laboratory techniques for the study of RNA brings together numerous novel methods that were hitherto only available through the primary literature. The editors - themselves experienced RNA researchers - have gathered expert authors from the US and Europe for the ultimate in everyday working knowledge. In more than 300 detailed protocols, all the techniques... |
 | Heal Your Body Naturally: The Power of RNA A layman's guide to RNA and its use for optimal health. "The field of RNA derived therapeutics is one of the most exciting to be explored in the last 20 years; one that has the promise of improving medical practice in areas of great unmet medical need." Richard Gaynor, VP Eli Lilly Pharmaceutical Company Modern Drug Discover, April... |
 | Modification And Editing Of Rna |
 | WHO DOWNED THE ACES IN WORLD WAR ONE: Facts, Figures and Photos on the Fate of Over 300 Top Pilots of the RFC, RNAS, RAF, French and German Air Services by Norman Franks A chronological account of both sides of the fighting, resulting in an over-view of events in the air in World War I. The account deals not just with the deaths, but also with the missing, the wounded, the POWs, and with aces both great and... |
 | Multiplication of RNA Plant Viruses by C.L. Mandahar Multiplication is the basic biological function of all organisms and is dependent upon replication of genomes. This is also true of plant viruses even though they possess a minimum of essential genetic information. Phylogenetically, replication-associated genes constitute the core elements of RNA virus genomes while other gene modules are considered as accessory elements. However, the biochemical... |
 | RNA Interference (Current Topics in Microbiology and Immunology) (Current Topics in Microbiology and Immunology) In the last few years the major effect that RNAi has had in invertebrate systems like C.elegans and drosophila is beginning to take hold in mammalian systems through both single gene knockdown experiments and genome-scale screens. In the next decade, there will no doubt be both notable successes and failures as we attempt to apply this genetic tool to various biological problems for the first... |
 | RNA Interference (Principles and Protocols) The Principles & Protocols Series is designed for upper level undergraduates, postgraduates and researchers, particularly those new to a field. Books in the series outline the theoretical background to experimental approaches, followed by bullet-point protocols, which are generic and can be adapted for particular systems. RNA interference (RNAi) has been one of the most exciting and significant... |
| © 2008 BrightSurf.com |